INLIF Ltd (INLF): Financial results for H1 2026

INLIF Ltd (INLF) furnished an SEC Form 6-K — earnings release. Exhibit 99.3 INLIF LIMITED Reports First Half of Fiscal Year 2026 Financial Results Quanzhou, China, September 24, 2026 /PRNewswire/ -- INLIF LIMITED (Nasdaq: INLF) (together with all its subsidiaries and consolidated entities, the “Company” or “INLIF”), a company engaged in the

Original reporting
Published Sep 24, 2026, 9:18 PM UTC
Analysis
AlphAI AI DeskAI-generated
Added to AlphAI Sep 24, 2026, 9:22 PM UTC. Informational, not investment advice.
How this was made
AlphAI summarizes source reporting and applies a structured AI analysis for relevance, timing, sentiment and ticker impact. Always verify material claims with the original publisher.
AlphAI market briefEarnings
Primary signal
$INLF
Bullish
high confidence
Mentioned
$INLF
Relevance
7/10
AlphAI data visualization · based on SEC EDGAR 6-K
Decision brief

The 30-second read

$INLFBullishMed
01

Why it matters

The earnings beat demonstrates successful execution of its diversification strategy, but the need for continued capital raises introduces execution risk.

02

Market read

First‑time earnings release for H1 2026 with a profit swing, likely to move the stock in the short term.

03

What to watch

Upcoming PIPE and ATM program could dilute existing shareholders and affect valuation.

Relevance 7/10Novelty 7/10Timing: after-hours Sep 24 2026
AlphAI · Earnings readINLF · H1 2026 · ended June 30, 2026

INLIF reported first-half revenue growth, a sharp gross-margin expansion and net income of $1.01 million, while funding operating and investing cash outflows through PIPE and ATM proceeds.

✓Solid half-year

Revenue increased 26.01%, gross profit increased 158.77%, gross profit margin rose to 35.95%, and the Company returned to net income from a prior-year net loss. Cash balances increased following PIPE and ATM financing, although operating and investing activities used cash.

Revenue
$12,942,657
26.01% y/y
Sales of manipulator arms and installation and warranty services, first half of fiscal year 2026
$4.97M
13.74% y/y
EPS · other
$10.01

Key metrics

as reported
MetricValueq/qy/y
Revenue, six months ended June 30, 2026other$12,942,657–26.01%
Cost of revenues, six months ended June 30, 2026other$(8,290,252)–decrease of 2.16%
Gross profit, six months ended June 30, 2026other$4,652,405–158.77%
Gross profit margin, six months ended June 30, 2026other35.95%––
Selling expenses, six months ended June 30, 2026other$(618,931)–50.21%
General and administrative expenses, six months ended June 30, 2026other$(1,759,047)–decrease of 34.42%
Research and development expenses, six months ended June 30, 2026other$(1,149,759)–49.18%
Total operating expenses, six months ended June 30, 2026other$(3,527,737)–decrease of 8.73%
Operating income (loss), six months ended June 30, 2026other$1,124,668––
Interest income, six months ended June 30, 2026other$12,389––
Interest expenses, six months ended June 30, 2026other$(63,367)––
Other income, net, six months ended June 30, 2026other$45,030––
Other expense, net, six months ended June 30, 2026other$(3,972)––
Exchange gain, six months ended June 30, 2026other$19,358––
Total other income, net, six months ended June 30, 2026other$9,438––
Income (loss) before income tax, six months ended June 30, 2026other$1,134,106––
Income tax (expenses) benefits, six months ended June 30, 2026other$(125,096)––
Net income (loss), six months ended June 30, 2026other$1,009,010––
Comprehensive income (loss), six months ended June 30, 2026other$1,848,937––
Earnings (loss) per share, basic and diluted, six months ended June 30, 2026other$10.01––
Weighted average number of shares, six months ended June 30, 2026other100,826––
Net cash used in operating activities, six months ended June 30, 2026other$(3,268,412)––
Net cash used in investing activities, six months ended June 30, 2026other$(14,882,615)––
Net cash provided by financing activities, six months ended June 30, 2026other$56,248,985––
Net increase (decrease) in cash, six months ended June 30, 2026other$38,748,175––

Segments

SegmentRevenueq/qy/y
Sales of manipulator arms and installation and warranty services, first half of fiscal year 2026Higher purchase volumes from certain existing customers and contributions from newly acquired customers.$4.97M–13.74%
Sales of accessories, first half of fiscal year 2026Sales remained relatively stable compared with the prior-year period.$400K–3.04%
Sales of raw materials and scraps, first half of fiscal year 2026Lower customer demand for certain raw materials and a more demand-driven procurement approach, with production and inventory controls reducing scraps.$4.2M––
Sales of installation services, first half of fiscal year 2026Lower installation volumes, shorter installation time for certain products, and more customers performing installation with their own personnel or requiring limited technical assistance.$6,528––
Sales of intelligent equipment, first half of fiscal year 2026Equipment used primarily in the new energy sector, driven by customer needs for new production lines, capacity expansion and automation upgrades; it accounted for 25.97% of total revenue.$3.36M––

What drove it

  • Net revenue growth reflected higher sales of manipulator arms, including installation and warranty services, higher accessory sales, and sales of intelligent equipment.
  • Intelligent equipment generated $3.36 million in revenue and had no revenue contribution in the same period last year.
  • Gross profit improvement reflected higher gross profit from manipulator arms, raw materials and scraps, and intelligent equipment.
  • General and administrative expenses declined primarily because no comparable equity grants were made in the first half of 2026 after grants to three key administrative employees in the first half of 2025.
  • Research and development headcount increased from 31 in June 2025 to 72 in June 2026, and industrial robots remained in research, development and product validation stages.

Concerns

  • Net cash used in operating activities was $(3,268,412) despite net income of $1,009,010.
  • Net cash used in investing activities was $(14,882,615), including $(11,837,047) of purchases of property, plant, and equipment.
  • Accounts receivable increased to $8,842,220 as of June 30, 2026 from $5,906,938 as of December 31, 2025.
  • Bank loans increased to $6,969,090 as of June 30, 2026 from $4,618,839 as of December 31, 2025.
  • Selling expenses and research and development expenses increased 50.21% and 49.18%, respectively.
  • Industrial robots remained in the research, development and product validation stages during the period.

What to watch

  • Sales and mix contribution from intelligent equipment, which generated $3.36 million and accounted for 25.97% of total revenue during the period.
  • Demand for manipulator arms from existing and newly acquired customers.
  • Operating cash flow, accounts receivable and inventory movements.
  • The level and timing of property, plant, and equipment investment.
  • Development and product validation progress for industrial robots.
  • Use of capital raised through the PIPE offering and ATM offering.

Balance sheet and cash flow

  • Cash and cash equivalents were $45,465,962 as of June 30, 2026, compared with $6,717,787 as of December 31, 2025.
  • Short-term investments were $3,000,000 as of June 30, 2026, compared with — as of December 31, 2025.
  • Accounts receivable, net were $8,842,220 as of June 30, 2026, compared with $5,906,938 as of December 31, 2025.
  • Inventories were $6,747,700 as of June 30, 2026, compared with $5,497,426 as of December 31, 2025.
  • Property, plant, and equipment, net was $16,201,530 as of June 30, 2026, compared with $4,248,793 as of December 31, 2025.
  • Total assets were $82,863,343 as of June 30, 2026, compared with $24,777,352 as of December 31, 2025.
  • Bank loans were $6,969,090 as of June 30, 2026, compared with $4,618,839 as of December 31, 2025.
  • Total liabilities were $11,384,801 as of June 30, 2026, compared with $8,642,483 as of December 31, 2025.
  • Total shareholders’ equity was $71,478,542 as of June 30, 2026, compared with $16,134,869 as of December 31, 2025.
  • Purchase of property, plant, and equipment was $(11,837,047) for the six months ended June 30, 2026, compared with $(618,796) for the same period of 2025.
  • Net proceeds from PIPE offering were $32,344,244 for the six months ended June 30, 2026.
  • Net proceeds from ATM offering were $21,150,492 for the six months ended June 30, 2026.

Analysis

INLIF reported $12,942,657 of revenue for the six months ended June 30, 2026, versus $10,270,988 in the prior-year period, with the release citing a 26.01% increase. Growth came from manipulator arms and related installation and warranty services, accessories, and the new intelligent equipment business. Intelligent equipment produced $3.36 million of sales, had no contribution in the prior-year period, and accounted for 25.97% of total revenue. These gains were partly offset by lower sales of raw materials and scraps and lower installation-service revenue.

The profit profile improved substantially. Cost of revenues declined to $(8,290,252) from $(8,473,079), while gross profit increased to $4,652,405 from $1,797,909. Gross profit margin increased to 35.95% from 17.50%. The release attributes gross-profit growth to manipulator arms, raw materials and scraps, and intelligent equipment, partly offset by lower gross profit from accessories and installation services. Operating income was $1,124,668, compared with an operating loss of $(2,067,293), and net income was $1,009,010, compared with a net loss of $(1,975,420).

Operating expenses declined to $(3,527,737) from $(3,865,202), despite higher spending on sales and research and development. Selling expenses increased to $(618,931), reflecting compensation, entertainment, travel and transportation expenses associated with sales expansion. Research and development expenses increased to $(1,149,759), as the R&D team expanded from 31 to 72 employees and the Company continued industrial-robot development. General and administrative expenses declined to $(1,759,047), primarily due to the absence of comparable share-based compensation grants that were made to three key administrative employees in the prior-year period.

Liquidity increased through financing activity. Cash and cash equivalents were $45,465,962 at June 30, 2026, compared with $6,717,787 at December 31, 2025. Net cash provided by financing activities was $56,248,985, including $32,344,244 of net PIPE proceeds and $21,150,492 of net ATM proceeds. The Company nonetheless used $(3,268,412) in operating activities and $(14,882,615) in investing activities, including $(11,837,047) for property, plant, and equipment. Bank loans rose to $6,969,090 from $4,618,839.

No forward financial guidance was provided. The release states that management intends to focus on technological innovation, organic growth and expansion of new business initiatives. Key reported execution markers are continued demand for manipulator arms, the revenue contribution and margin profile of intelligent equipment, industrial-robot product validation, operating cash use, and the pace of investment following the capital raises.

Management, verbatim

This growth was driven by the expansion of our customer base, rising demand for manipulator arms, and, in particular, sales from our newly launched intelligent equipment business, which generated $3.36 million in revenue and accounted for 25.97% of total revenue during the period, compared with no revenue contribution in the same period last year.

Rongjun Xu, Chief Executive Officer

Alongside increased investments in sales, technology, and new product development, we maintained disciplined cost management across the organization.

Rongjun Xu, Chief Executive Officer

Not in the filing

stated, not guessed
  • Forward revenue, gross-margin, operating-expense, tax-rate or other financial guidance was not provided.
  • Previous-period outlook was not provided.
  • Non-GAAP financial metrics were not provided.
  • Free cash flow was not provided.
  • Dividend and share-repurchase information was not provided.
  • An effective tax rate was not provided.
  • Prior-quarter comparisons were not provided.
  • Operating margin was not provided.
  • A total debt figure was not provided.

Written by an AI language model from the company’s SEC earnings filing (Form 8-K Item 2.02, or Form 6-K for a foreign private issuer). Every figure is checked against the filing text, and a metric the filing does not print, or whose value, prior period and change do not add up, is dropped from the metrics. The model can still misread a table, in the metrics or in the text, so check a number in the filing before you rely on it. Consensus estimates, price targets and share-price reactions are not shown because they are not in the filing. AI-generated research, not investment advice.

Background

INLF is a Nasdaq‑listed provider of manipulator arms for injection molding machines, expanding into intelligent equipment and new energy sectors.

Company-level read

Ticker impact

$INLFBullishHigh confidence
Context

INLF reported H1 2026 results with revenue up 26% and a swing to $1.01M net income, marking a turnaround from a loss last year.

Expected impact

Potential short‑term price rally as investors digest the earnings beat.

Evidence & confidence

Revenue growth, margin improvement, and a profitable quarter for a previously loss‑making microcap typically drive buying pressure.

Market effects

Highlights growth in the industrial automation and intelligent equipment segment, potentially benefiting peers.

Positive signal for Chinese‑based manufacturing tech firms listed in the U.S.

Limited to niche automation sector; unlikely to affect broader indices.

Counterpoint

The company remains small and cash‑flow negative; growth may not be sustainable without further capital.

Key entities

  • Rongjun Xu

    CEO of INLF who commented on the results.

Every INLF earnings report

This story covers one filing. The ticker page keeps them all: each quarter's reported metrics with year-over-year and sequential comparisons, segments, guidance, and how the numbers landed against the company's own prior outlook.

Related articles

$INLFMedAI 8/10

INLIF LIMITED Accelerates Strategic Layout in New Energy Sector, Securing $4.4 Million First Order for Battery Cell Packing Machines

INLIF Limited (NASDAQ: INLF) said it confirmed commercial delivery of its first battery cell packing machines order, worth nearly RMB 30 million (about US$4.4 million). The contract includes 14 units for a domestic battery manufacturer; the customer also placed a follow-on order for six more units. INLIF estimates up to 50 units by end-2026 (about RMB 100 million+), subject to demand and execution risks.

$AVLNMed

Avalyn Reports Third Quarter 2026 Financial Results and Recent

Avalyn Pharma Inc. (AVLN) filed an SEC Form 8-K — Results of Operations and Financial Condition. Avalyn Reports Third Quarter 2026 Financial Results and Recent Business Highlights Initiated Phase 1 study of AP03, a fixed dose combination of nebulized pirfenidone and nintedanib, in healthy volunteers Presented new AP01 data at ERS Congress and published detailed results from

$MGTXHigh

MeiraGTx Reports Third Quarter 2026 Financial and Operational Results

MeiraGTx Holdings plc (MGTX) filed an SEC Form 8-K — Results of Operations and Financial Condition. Exhibit 99.1 MeiraGTx Reports Third Quarter 2026 Financial and Operational Results ● Submission of Marketing Authorisation Application (MAA) to the European Medicines Agency (EMA) for botaretigene sparoparvovec (bota-vec) for the treatment of X-linked retinitis pigmentosa (XLRP)

$VOXRMed

VOX ROYALTY CORP. (VOXR): Financial results for Q3 2026

VOX ROYALTY CORP. (VOXR) furnished an SEC Form 6-K — earnings release. EXHIBIT 99.5 VOX ROYALTY REPORTS Q3 2026 RESULTS AND DECLARES QUARTERLY DIVIDEND DENVER – November 11, 2026 – Vox Royalty Corp. (NASDAQ: VOXR ) (TSX: VOXR ) (“ Vox ” or the “ Company ”), a returns-focused mining royalty and streaming company, is pleased to announce its operating

$LUCDMed

Lucid Diagnostics Provides Business Update and Reports Third Quarter 2026 Financial Results

Lucid Diagnostics Inc. (LUCD) filed an SEC Form 8-K — Results of Operations and Financial Condition. Exhibit 99.1 Lucid Diagnostics Provides Business Update and Reports Third Quarter 2026 Financial Results EsoGuard ® now fully reimbursed by Medicare nationwide, launching a new phase of accelerating commercialization with record monthly test volume to start the fourth quarter Con

$AKTSMed

Aktis Oncology Reports Third-Quarter Financial Results and Highlights Clinical Trial Progress

Aktis Oncology, Inc. (AKTS) filed an SEC Form 8-K — Results of Operations and Financial Condition. Aktis Oncology Reports Third-Quarter Financial Results and Highlights Clinical Trial Progress • Initiated the Company’s third Phase 1b clinical trial, BActinium-2, broadening the evaluation of AKY-2519 to lung cancer and other B7-H3 expressing tumors • Started first backfill coho